Latest filings (excl ownership)
15-12B
Securities registration termination
3 Apr 20
EFFECT
Notice of effectiveness
3 Apr 20
EFFECT
Notice of effectiveness
3 Apr 20
EFFECT
Notice of effectiveness
3 Apr 20
8-K
Entry into a Material Definitive Agreement
2 Apr 20
NT 10-K
Notice of late annual filing
31 Mar 20
POS AM
Prospectus update (post-effective amendment)
31 Mar 20
POS AM
Prospectus update (post-effective amendment)
31 Mar 20
POS AM
Prospectus update (post-effective amendment)
30 Mar 20
S-8 POS
Registration of securities for employees (post-effective amendment)
30 Mar 20
S-8 POS
Registration of securities for employees (post-effective amendment)
30 Mar 20
S-8 POS
Registration of securities for employees (post-effective amendment)
30 Mar 20
S-8 POS
Registration of securities for employees (post-effective amendment)
30 Mar 20
S-8 POS
Registration of securities for employees (post-effective amendment)
30 Mar 20
424B5
Prospectus supplement for primary offering
30 Mar 20
8-K
Valeritas Receives Court Approval of Sale of Business to Zealand Pharma
20 Mar 20
8-K
Entry into a Material Definitive Agreement
18 Mar 20
8-K
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
16 Mar 20
25-NSE
Exchange delisting
9 Mar 20
8-K
Departure of Directors or Certain Officers
28 Feb 20
8-K
Entry into a Material Definitive Agreement
14 Feb 20
8-K
Valeritas Announces Agreement for Zealand Pharma to Acquire Business and Retain Employees
10 Feb 20
8-K
Departure of Directors or Certain Officers
10 Jan 20
8-K
Departure of Directors or Certain Officers
23 Dec 19
8-K
Valeritas Experiences a Temporary Supply Disruption Resulting in Revised Preliminary Financial Results for 2019 Fourth Quarter and Full Year
20 Dec 19
8-K
Other Events
11 Dec 19
8-K
Valeritas Presents Positive h-Patchâ„¢ CBD Study Data as a Late-Breaking Presentation at the American Epilepsy Society 2019 Annual Meeting
9 Dec 19
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
20 Nov 19
8-K
Other Events
15 Nov 19
10-Q
2019 Q3
Quarterly report
12 Nov 19
8-K
Valeritas Announces Third Quarter 2019 Financial Results
12 Nov 19
8-K
Other Events
21 Oct 19
UPLOAD
Letter from SEC
8 Oct 19
CORRESP
Correspondence with SEC
4 Oct 19
8-K
Valeritas Reduces its Long-Term Debt Obligation Nearly 60% by Exchanging $25.0 Million of Debt for Series B Convertible Preferred Stock
2 Oct 19
UPLOAD
Letter from SEC
24 Sep 19
8-K
Other Events
20 Sep 19
8-K
Other Events
13 Sep 19
Latest ownership filings
SC 13G/A
Beneficial ownership report (amended)
14 Feb 20
3
Melanie R. Hansen
23 Jan 20
4
Steven Boyd
23 Dec 19
SC 13G/A
Valeritas Holdings Inc.
23 Dec 19
4
Change in insider ownership
2 Oct 19
SC 13D/A
Valeritas Holdings Inc.
2 Oct 19
SC 13G/A
Valeritas Holdings Inc.
10 Sep 19
4
Steven Boyd
28 May 19
4
Steven Boyd
21 May 19
4
Joseph M Mandato
16 May 19
4
KATHERINE D CROTHALL
16 May 19
4
BRIAN K ROBERTS
16 May 19
4
Peter Devlin
16 May 19
4
Rodney Altman
16 May 19
4
Steven Boyd
14 May 19
4
Steven Boyd
27 Mar 19
4
GEOFFREY JENKINS
8 Mar 19
4
Joseph Saldanha
8 Mar 19
4
Matt Nguyen
8 Mar 19
4
Mark William Conley
8 Mar 19
4
Erick Lucera
8 Mar 19
4
John Edward Timberlake
8 Mar 19
SC 13G/A
Valeritas Holdings Inc.
14 Feb 19
SC 13G
Valeritas Holdings Inc.
14 Feb 19
SC 13G/A
Valeritas Holdings Inc.
5 Feb 19
SC 13G
Valeritas Holdings Inc.
11 Jan 19
4
Steven Boyd
27 Dec 18
4
Steven Boyd
20 Dec 18
4
Steven Boyd
10 Dec 18
SC 13G
Valeritas Holdings Inc.
10 Dec 18
4
Matt Nguyen
10 Dec 18
4
John Edward Timberlake
7 Dec 18
4
Peter Devlin
6 Dec 18
4
GEOFFREY JENKINS
30 Nov 18
4
Steven Boyd
29 Nov 18
4
Joseph M Mandato
28 Nov 18
4
Peter Devlin
28 Nov 18
4
Steven Boyd
26 Nov 18
4
John Edward Timberlake
26 Nov 18
4
John Edward Timberlake
26 Nov 18